- Home
- UTHR vs GEN Comparison
UTHR vs GEN Comparison
Compare UTHR & GEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- GEN
- Stock Information
- Founded
- UTHR 1996
- GEN 1982
- Country
- UTHR United States
- GEN United States
- Employees
- UTHR N/A
- GEN N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- GEN Computer Software: Prepackaged Software
- Sector
- UTHR Health Care
- GEN Technology
- Exchange
- UTHR Nasdaq
- GEN Nasdaq
- Market Cap
- UTHR 16.1B
- GEN 17.0B
- IPO Year
- UTHR 1999
- GEN N/A
- Fundamental
- Price
- UTHR $367.97
- GEN $27.32
- Analyst Decision
- UTHR Buy
- GEN Buy
- Analyst Count
- UTHR 14
- GEN 4
- Target Price
- UTHR $378.36
- GEN $28.75
- AVG Volume (30 Days)
- UTHR 280.3K
- GEN 3.1M
- Earning Date
- UTHR 02-19-2025
- GEN 01-30-2025
- Dividend Yield
- UTHR N/A
- GEN 1.82%
- EPS Growth
- UTHR 25.10
- GEN N/A
- EPS
- UTHR 22.72
- GEN 0.99
- Revenue
- UTHR $2,756,200,000.00
- GEN $3,863,000,000.00
- Revenue This Year
- UTHR $26.19
- GEN $3.93
- Revenue Next Year
- UTHR $10.79
- GEN $3.33
- P/E Ratio
- UTHR $16.19
- GEN $27.64
- Revenue Growth
- UTHR 25.04
- GEN 2.44
- 52 Week Low
- UTHR $208.62
- GEN $19.08
- 52 Week High
- UTHR $417.82
- GEN $31.72
- Technical
- Relative Strength Index (RSI)
- UTHR 53.51
- GEN 40.98
- Support Level
- UTHR $357.25
- GEN $26.55
- Resistance Level
- UTHR $372.34
- GEN $27.96
- Average True Range (ATR)
- UTHR 8.70
- GEN 0.43
- MACD
- UTHR 0.91
- GEN 0.08
- Stochastic Oscillator
- UTHR 79.59
- GEN 54.61
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About GEN Gen Digital Inc.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.